CompanyHealthAi
HelixNano
HelixNano is a Cambridge/Boston-based biotechnology company building what it calls the world's most advanced mRNA platform - combining synthetic biology and machine learning to make vaccines and therapies that augment the immune system. Founded in 2014 by sci-fi novelist and mathematician Hannu Rajaniemi and synthetic biologist Nikolai Eroshenko, the Y Combinator-backed startup has pursued variant-resistant COVID-19 vaccine candidates and machine-learning-designed personalized cancer vaccines built on 'precision neoantigens'.
2014Founded
CambridgeHQ
$45,000,000Series A
mrnabiotechnext-generation therapeuticscancer vaccinesimmunotherapyneoantigens